| Trial ID: | L0444 |
| Source ID: | NCT04216693
|
| Associated Drug: |
Digoxin
|
| Title: |
Efficacy and Safety of Digoxin in the Treatment of Adults Patients With Non-alcoholic Steatohepatitis: a Multi-center, Randomized, Placebo-controlled Trial
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Steatohepatitis
|
| Interventions: |
Drug: Digoxin tablet;Other: Placebo
|
| Outcome Measures: |
Two point change in histological NAFLD activity score (NAS);Proportion of subjects with at least a 30% change in % steatosis relative to screeningChange in the mean concentration of serum aspartate aminotransferase (AST);Change in the mean concentration of serum alanine aminotransferase (ALT);Change in liver histological fibrosis staging
|
| Sponsor/Collaborators: |
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
|
| Gender: |
All
|
| Age: |
18 Years70 Years
|
| Phases: |
Phase 2
|
| Enrollment: |
60
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
| Start Date: |
31/12/2019
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
12 December 2020
|
| Locations: |
China
|
| URL: |
https://clinicaltrials.gov/show/NCT04216693
|
